DMAAU
Drugs Made In America Acquisition Corp.
Price Chart
Latest Quote
$10.68
+0.00 (+0.00%)
Current Price
| Previous Close | $10.68 |
| Open | $10.69 |
| Day High | $10.68 |
| Day Low | $10.68 |
| Volume | 2,142 |
Stock Information
| Shares Outstanding | 29.17M |
| Total Debt | $100K |
| Cash Equivalents | $15K |
| Net Income | $6.66M |
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $257.66M |
| Income | $6.66M |
| Book/sh | $-0.30 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.03 |
| EPS Growth TTM | 57.10% |
Returns & Margins
Ownership
| Insider Ownership | 17.88% |
| Institutional Ownership | 1.54% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -35.13 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $11.01 |
| SMA50 | $10.75 |
| SMA200 | $10.57 |
| RSI | 47.98 |
| ATR | 0.2864 |
| Shares Float | 19.67M |
| Short Ratio | 1.01 |
Performance History
| Week | -6.27% |
| Month | +0.28% |
| Quarter | +1.05% |
| 6 Months | +1.14% |
| YTD | +1.14% |
| Year | +1.73% |
| 10 Years | +6.10% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $10.61 | 0 |
| 2026-06-17 | $10.61 | 2,042 |
| 2026-06-16 | $11.32 | 0 |
| 2026-06-15 | $11.32 | 0 |
| 2026-06-12 | $11.32 | 0 |
| 2026-06-11 | $11.32 | 0 |
| 2026-06-10 | $11.32 | 0 |
| 2026-06-09 | $11.32 | 0 |
| 2026-06-08 | $11.32 | 798 |
| 2026-06-05 | $11.70 | 437 |
| 2026-06-04 | $10.85 | 0 |
| 2026-06-03 | $10.85 | 2,370 |
| 2026-06-02 | $11.05 | 6,457 |
| 2026-06-01 | $10.71 | 0 |
| 2026-05-29 | $10.71 | 0 |
| 2026-05-28 | $10.71 | 610 |
| 2026-05-27 | $10.74 | 8,452 |
| 2026-05-26 | $10.69 | 3,371 |
| 2026-05-22 | $10.90 | 11,060 |
| 2026-05-21 | $10.90 | 3,842 |
| 2026-05-20 | $10.58 | 0 |
| 2026-05-19 | $10.58 | 0 |
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 |
|---|---|
| Revenue | |
| Total Revenue | $0 |
| Operating Revenue | $0 |
| Expenses | |
| Total Expenses | $2,816,013 |
| Net Non Operating Interest Income Expense | $8,756,656 |
| Operating Expense | $2,816,013 |
| General And Administrative Expense | $2,816,013 |
| Income & Earnings | |
| Net Income From Continuing Operation Net Minority Interest | $5,940,643 |
| Net Interest Income | $8,756,656 |
| Interest Income | $8,756,656 |
| Normalized Income | $5,940,643 |
| Net Income From Continuing And Discontinued Operation | $5,940,643 |
| Total Operating Income As Reported | $-2,816,013 |
| Net Income Common Stockholders | $5,940,643 |
| Net Income | $5,940,643 |
| Net Income Including Noncontrolling Interests | $5,940,643 |
| Net Income Continuous Operations | $5,940,643 |
| Pretax Income | $5,940,643 |
| Interest Income Non Operating | $8,756,656 |
| Operating Income | $-2,816,013 |
| Other | |
| Tax Effect Of Unusual Items | $0 |
| Tax Rate For Calcs | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,816,013 |
| EBITDA (Bullshit earnings) | $-2,816,013 |
| EBIT | $-2,816,013 |
| Diluted NI Availto Com Stockholders | $5,940,643 |
| Selling General And Administration | $2,816,013 |
| Other Gand A | $2,816,013 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $232,642,675 | $-244,845 |
| Total Assets | $239,918,847 | $550,824 |
| Total Non Current Assets | $239,906,656 | $545,833 |
| Other Non Current Assets | $239,906,656 | - |
| Non Current Deferred Assets | $0 | $545,833 |
| Current Assets | $12,191 | $4,991 |
| Other Current Assets | $6,054 | $3,640 |
| Cash Cash Equivalents And Short Term Investments | $6,137 | $1,351 |
| Cash And Cash Equivalents | $6,137 | $1,351 |
| Cash Financial | $6,137 | $1,351 |
| Prepaid Assets | - | $3,640 |
| Debt | ||
| Net Debt | - | $660,973 |
| Total Debt | - | $662,324 |
| Current Debt And Capital Lease Obligation | - | $662,324 |
| Current Debt | - | $662,324 |
| Other Current Borrowings | - | $662,324 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $7,276,172 | $795,669 |
| Total Non Current Liabilities Net Minority Interest | $6,900,000 | $0 |
| Tradeand Other Payables Non Current | $6,900,000 | $0 |
| Current Liabilities | $376,172 | $795,669 |
| Payables And Accrued Expenses | $376,172 | $133,345 |
| Payables | $222,184 | $77,280 |
| Accounts Payable | $222,184 | $77,280 |
| Equity | ||
| Common Stock Equity | $232,642,675 | $-244,845 |
| Total Equity Gross Minority Interest | $232,642,675 | $-244,845 |
| Stockholders Equity | $232,642,675 | $-244,845 |
| Retained Earnings | $-7,265,053 | $-279,845 |
| Other | ||
| Ordinary Shares Number | $33,717,143 | $30,457,143 |
| Share Issued | $33,717,143 | $30,457,143 |
| Tangible Book Value | $232,642,675 | $-244,845 |
| Invested Capital | $232,642,675 | $417,479 |
| Working Capital | $-363,981 | $-790,678 |
| Total Capitalization | $232,642,675 | $-244,845 |
| Additional Paid In Capital | $0 | $34,014 |
| Capital Stock | $239,907,728 | $986 |
| Common Stock | $239,907,728 | $986 |
| Preferred Stock | $0 | $0 |
| Current Accrued Expenses | $153,988 | $56,065 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 |
|---|---|
| Free Cash Flow | |
| Free Cash Flow | $-539,187 |
| Operating Activities | |
| Operating Cash Flow | $-539,187 |
| Cash Flow From Continuing Operating Activities | $-539,187 |
| Investing Activities | |
| Investing Cash Flow | $-231,150,000 |
| Cash Flow From Continuing Investing Activities | $-231,150,000 |
| Net Other Investing Changes | $-231,150,000 |
| Financing Activities | |
| Issuance Of Capital Stock | $232,050,000 |
| Financing Cash Flow | $231,693,973 |
| Cash Flow From Continuing Financing Activities | $231,693,973 |
| Net Other Financing Charges | $543,973 |
| Net Common Stock Issuance | $232,050,000 |
| Common Stock Issuance | $232,050,000 |
| Other | |
| Repayment Of Debt | $-900,000 |
| Issuance Of Debt | $0 |
| End Cash Position | $6,137 |
| Beginning Cash Position | $1,351 |
| Changes In Cash | $4,786 |
| Net Issuance Payments Of Debt | $-900,000 |
| Net Short Term Debt Issuance | $-900,000 |
| Short Term Debt Payments | $-900,000 |
| Short Term Debt Issuance | $0 |
| Change In Working Capital | $138,850 |
| Change In Payables And Accrued Expense | $144,904 |
| Change In Payable | $144,904 |
| Change In Account Payable | $144,904 |
| Change In Prepaid Assets | $-6,054 |
| Other Non Cash Items | $-6,618,680 |
| Net Income From Continuing Operations | $5,940,643 |
Fetched: 2026-06-17